Phase I/IIa Study of H002 in NSCLC With Active EGFR Mutation

Clinical trial NCT05519293 · UNKNOWN

Trial details

NCT number: NCT05519293
Sponsor: RedCloud Bio
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2022-12-15
Primary completion: 2025-02-28
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.